These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33383263)

  • 1. Can policy affect initiation of addictive substance use? Evidence from opioid prescribing.
    Sacks DW; Hollingsworth A; Nguyen T; Simon K
    J Health Econ; 2021 Mar; 76():102397. PubMed ID: 33383263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic.
    Stein BD; Sheng F; Taylor EA; Dick AW; Sorbero M; Pacula RL
    Drug Alcohol Depend; 2022 Feb; 231():109232. PubMed ID: 35007956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Drug Monitoring Programs Produce a Limited Impact on Painkiller Prescribing in Medicare Part D.
    Yarbrough CR
    Health Serv Res; 2018 Apr; 53(2):671-689. PubMed ID: 28101955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.
    Mauri AI; Townsend TN; Haffajee RL
    Milbank Q; 2020 Mar; 98(1):57-105. PubMed ID: 31800142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
    Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
    Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid Prescribing Laws Are Not Associated with Short-term Declines in Prescription Opioid Distribution.
    Davis CS; Piper BJ; Gertner AK; Rotter JS
    Pain Med; 2020 Mar; 21(3):532-537. PubMed ID: 31365095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids.
    Moride Y; Lemieux-Uresandi D; Castillon G; de Moura CS; Pilote L; Faure M; Bernartsky S
    Pain Physician; 2019 May; 22(3):229-240. PubMed ID: 31151331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences.
    Kim B
    J Health Econ; 2021 Jan; 75():102408. PubMed ID: 33316762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis.
    Dickson-Gomez J; Krechel S; Spector A; Weeks M; Ohlrich J; Green Montaque HD; Li J
    Subst Abuse Treat Prev Policy; 2022 Jul; 17(1):55. PubMed ID: 35864522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Doctor and pharmacy shopping": A fading signal for prescription opioid use monitoring?
    Delcher C; Harris DR; Park C; Strickler GK; Talbert J; Freeman PR
    Drug Alcohol Depend; 2021 Apr; 221():108618. PubMed ID: 33677354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of state rules on opioid prescribing in Indiana.
    Al Achkar M; Grannis S; Revere D; MacKie P; Howard M; Gupta S
    BMC Health Serv Res; 2018 Jan; 18(1):29. PubMed ID: 29347984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages.
    Haffajee RL; Mello MM; Zhang F; Zaslavsky AM; Larochelle MR; Wharam JF
    Health Aff (Millwood); 2018 Jun; 37(6):964-974. PubMed ID: 29863921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription Drug Monitoring Programs and Opioid Prescriptions for Disability Conditions.
    Ozturk O; Hong Y; McDermott S; Turk M
    Appl Health Econ Health Policy; 2021 May; 19(3):415-428. PubMed ID: 33251552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
    Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
    Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.
    Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF
    J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.
    Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM
    BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
    Manders L; Abd-Elsayed A
    Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in opioid agonist treatment initiation among people prescribed opioids for pain following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis.
    Picco L; Xia T; Bell JS; Pearce C; Buchbinder R; Lubman DI; Nielsen S
    Drug Alcohol Rev; 2023 Nov; 42(7):1639-1646. PubMed ID: 37798947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.